Joseph Reilly, BS, PharmD, BCGP, and Andrew Skinner, MD, discuss the potential benefits of using live-jslm early on to treat CDI, as well as the implications of this new treatment.
Timothy Reilly, PharmD, BCPS, CGP, FASCP
Advertisement
Articles by Timothy Reilly, PharmD, BCPS, CGP, FASCP
Advertisement
Latest Updated Articles
Role of Live-JSLM in Treating Recurrent CDIPublished: May 19th 2023 | Updated:
- One Step at a Time: Improving Chronic Obstructive Pulmonary Disease Outcomes with Optimal Use of Medication Devices
Published: July 22nd 2013 | Updated:
- Transitions of Care for Patients with Acute Coronary Syndromes: The Role of Health-System and Community Pharmacists in Adherence to Antiplatelet Therapy
Published: September 16th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
2
Is Berberine Nature’s GLP-1?
3
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
4
Incidence of Invasive Fungal Infections Following BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma
5
